Articles

Rabbit antithymocyte globulin (Thymoglobulin®) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients

Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin;Institute of Medical Immunology, Charité CVK, Berlin;Experimental and Clinical Research Center (ECRC), Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité CVK, Berlin
Department of Medicine, Division of Gastroenterology, Infectiology and Rheumatology
Institute of Medical Immunology, Charité CVK, Berlin
BCRT Flow Cytometry Laboratory, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité CVK, Berlin
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Institute of Medical Immunology, Charité CVK, Berlin;Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité CVK, Berlin
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité CVK, Berlin
Vol. 98 No. 1 (2013): January, 2013 https://doi.org/10.3324/haematol.2012.067611